[Effect of fish oil concentrate on the lipoprotein profile of patients with type II diabetes mellitus]
- PMID: 1545765
[Effect of fish oil concentrate on the lipoprotein profile of patients with type II diabetes mellitus]
Abstract
Non-insulin-dependent diabetes mellitus (NIDDM) is associated with increased very-low-density lipoprotein (VLDL) and triglyceride concentrations as abnormalities of low-density lipoprotein (LDL) composition. Because fish oil has a strong triglyceride lowering effect in case of normolipemic subjects, we investigated the influence of supplementary fish oil diet in patients suffering from NIDDM (n = 19), who until now were not treated by drugs but only by diet. The study was started with a placebo-run-in-period for four weeks (phase I, 6 g rape seed oil capsules/d), followed by a verum period for twelve weeks (phase II, 6 g fish oil concentrate capsules/d), and a wash-out-period for four weeks (phase III, 6 g rape seed oil capsules/d). The fish oil supplementation contained at least 3 g eicosapentenoic and docosahexenoic acid. The lipoproteins, apolipoproteins, blood glucose, and insulin level (fasting and after load test) were checked at the beginning and at the end of each phase. In comparison to the placebo rape seed oil supplementation, the fish oil diet effected a decrease of serum triglycerides by 29%. LDL-cholesterol increased by 9%, HDL-cholesterol by 9% (especially HDL2-cholesterol), and apolipoprotein B by 4%. Apolipoprotein A-I was reduced by 9%. The fasting blood glucose and the glucose load test as the insulin level (fasting and after load test) showed no significant changes at the end of the verum period in comparison to the run-in-phase.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.Eur J Clin Nutr. 1994 Dec;48(12):859-65. Eur J Clin Nutr. 1994. PMID: 7889894 Clinical Trial.
-
Effects of glyburide treatment on serum lipoprotein and apolipoprotein concentrations and ratios in non-insulin-dependent diabetes mellitus.Clin Ther. 1988;10(4):392-400. Clin Ther. 1988. PMID: 3152618
-
Effects of marine n-3 fatty acid supplementation on lipoprotein subclasses measured by nuclear magnetic resonance in subjects with type II diabetes.Eur J Clin Nutr. 2008 Mar;62(3):419-29. doi: 10.1038/sj.ejcn.1602703. Epub 2007 Feb 28. Eur J Clin Nutr. 2008. PMID: 17327864 Clinical Trial.
-
Fish oil: what is the role in cardiovascular health?J Pharm Pract. 2012 Feb;25(1):69-74. doi: 10.1177/0897190011406983. J Pharm Pract. 2012. PMID: 21676848 Review.
-
Do n-3 fatty acids improve glucose tolerance and lipemia in diabetics?Curr Opin Lipidol. 1997 Feb;8(1):7-11. doi: 10.1097/00041433-199702000-00003. Curr Opin Lipidol. 1997. PMID: 9127704 Review.
Cited by
-
Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus.Cochrane Database Syst Rev. 2008 Jan 23;2008(1):CD003205. doi: 10.1002/14651858.CD003205.pub2. Cochrane Database Syst Rev. 2008. PMID: 18254017 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical